Search

Author/Creator Sesques, P.

2. REAL‐WORLD RESULTS ON CD19 CAR T‐CELL FOR 60 FRENCH PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE PROGRAM. (12th June 2019)

Authors:
Thieblemont, C.; Le Gouill, S.; Di Blasi, R.; Cartron, G.; Morschhauser, F.; Bachy, E.; Paillassa, J.; Bernard, S.; Tessoulin, B.; Gastine, T.; Fegueux, N.; Kanouni, T.; Manier, S.; Sesques, P.; Houot, R.; Haouin, C.; Tilly, H.; Salles, G.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
301
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. S260: A MATCHED COMPARISON OF TISAGENLECLEUCEL AND AXICABTAGENE CILOLEUCEL CAR T CELLS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-LIFE LYSA STUDY FROM THE FRENCH DESCAR-T REGISTRY. (23rd June 2022)

Authors:
Bachy, E.; Le Gouill, S.; Sesques, P.; Di Blasi, R.; Guillaume, M.; Cartron, G.; Beauvais, D.; Roulin, L.; Gros, F. X.; Rubio, M. T.; Bories, P.; Bay, J. O.; Castilla Llorente, C.; Choquet, S.; Casasnovas, R.-O.; Mothy, M.; Guidez, S.; Joris, M.; Loschi, M.; Carras, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
161
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗